Pharma Kenis: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharma Kenis
Largest movements
- Receivables within one year -€392,210
down €392,210 (-80.1%), from €489,658 to €97,448
of which Other amounts receivable: -€437,604
- Cash +€140,437
up €140,437 (+482.2%), from €29,122 to €169,559
mainly Receivables within one year (+€392,210) and Net result for the year (+€143,121)
- Intangible fixed assets -€45,000
no longer reported in 2025 (was €45,000)
- Debts after one year -€243,046
down €243,046 (-48.6%), from €500,554 to €257,507
- Reserves +€143,000
up €143,000 (+18.7%), from €765,360 to €908,360
of which Distributable reserves: +€143,000
- Accrued charges and deferred income -€126,000
down €126,000 (-99.9%), from €126,144 to €144
- Other debts -€52,500
no longer reported in 2025 (was €52,500)
- Current portion of long-term debt -€17,791
down €17,791 (-16.6%), from €106,998 to €89,206
- Gross operating margin -€24,178
down €24,178 (-9.5%), from €255,696 to €231,518
- Taxes -€9,050
down €9,050 (-11.9%), from €76,086 to €67,036
- Financial charges +€6,332
up €6,332 (+139.6%), from €4,536 to €10,868
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,589,443 | €1,277,900 | -€311,543 | -19.6% |
| Fixed assets | 21/28 | €1,070,561 | €1,010,790 | -€59,771 | -5.6% |
| Intangible fixed assets | 21 | €45,000 | - | -€45,000 | |
| Tangible fixed assets | 22/27 | €37,180 | €26,909 | -€10,271 | -27.6% |
| Plant, machinery and equipment | 23 | €295 | €293 | -€2 | -0.8% |
| Furniture and vehicles | 24 | €36,885 | €26,616 | -€10,269 | -27.8% |
| Financial fixed assets | 28 | €988,381 | €983,881 | -€4,500 | -0.5% |
| Current assets | 29/58 | €518,882 | €267,110 | -€251,772 | -48.5% |
| Amounts receivable within one year | 40/41 | €489,658 | €97,448 | -€392,210 | -80.1% |
| Trade receivables | 40 | €35,294 | €80,687 | +€45,393 | +128.6% |
| Other amounts receivable | 41 | €454,364 | €16,760 | -€437,604 | -96.3% |
| Cash at bank and in hand | 54/58 | €29,122 | €169,559 | +€140,437 | +482.2% |
| Deferred charges and accrued income | 490/1 | €102 | €103 | +€1 | +1.2% |
| Total equity and liabilities | 10/49 | €1,589,443 | €1,277,900 | -€311,543 | -19.6% |
| Equity | 10/15 | €778,138 | €921,259 | +€143,121 | +18.4% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €765,360 | €908,360 | +€143,000 | +18.7% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €763,500 | €906,500 | +€143,000 | +18.7% |
| Profit (loss) carried forward | 14 | €378 | €499 | +€121 | +31.9% |
| Amounts payable | 17/49 | €811,305 | €356,641 | -€454,664 | -56.0% |
| Amounts payable after more than one year | 17 | €500,554 | €257,507 | -€243,046 | -48.6% |
| Financial debts | 170/4 | €500,554 | €257,507 | -€243,046 | -48.6% |
| Amounts payable within one year | 42/48 | €184,607 | €98,989 | -€85,618 | -46.4% |
| Current portion of amounts payable after more than one year | 42 | €106,998 | €89,206 | -€17,791 | -16.6% |
| Trade debts | 44 | €1,442 | €1,571 | +€129 | +8.9% |
| Suppliers | 440/4 | €1,442 | €1,571 | +€129 | +8.9% |
| Taxes, remuneration and social security | 45 | €23,668 | €8,212 | -€15,456 | -65.3% |
| Taxes | 450/3 | €20,743 | €5,266 | -€15,477 | -74.6% |
| Remuneration and social security | 454/9 | €2,925 | €2,946 | +€21 | +0.7% |
| Other amounts payable | 47/48 | €52,500 | - | -€52,500 | |
| Accrued charges and deferred income | 492/3 | €126,144 | €144 | -€126,000 | -99.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,545 | €10,541 | -€3 | 0.0% |
| Other operating charges | 640/8 | €1,035 | €1,102 | +€67 | +6.5% |
| Non-recurring operating charges | 66A | €630 | - | -€630 | |
| Gross operating margin | 9900 | €255,696 | €231,518 | -€24,178 | -9.5% |
| Operating profit (loss) | 9901 | €243,486 | €219,874 | -€23,612 | -9.7% |
| Financial income | 75/76B | €193 | €1,151 | +€958 | +496.0% |
| Recurring financial income | 75 | €193 | €130 | -€63 | -32.6% |
| Non-recurring financial income | 76B | - | €1,020 | +€1,020 | |
| Financial charges | 65/66B | €4,536 | €10,868 | +€6,332 | +139.6% |
| Recurring financial charges | 65 | €4,536 | €10,868 | +€6,332 | +139.6% |
| Profit (loss) for the period before taxes | 9903 | €239,143 | €210,157 | -€28,986 | -12.1% |
| Income taxes | 67/77 | €76,086 | €67,036 | -€9,050 | -11.9% |
| Profit (loss) for the period | 9904 | €163,057 | €143,121 | -€19,937 | -12.2% |
| Profit (loss) for the period to be appropriated | 9905 | €163,057 | €143,121 | -€19,937 | -12.2% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.